Products for Research Use Only
RegisterLogin

AZ3451

CAT: 0013-GTR19166372-07Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19166372-07Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AZ3451 is a potent allosteric antagonist of protease-activated receptor 2 (PAR2), exhibiting an IC50 of 23 nM. This small molecule is a valuable research tool for investigating PAR2-mediated signaling in inflammation, pain, and cancer within in vitro and in vivo experimental models.
CAS Number
2100284-59-9
Product Name Alternative
Thrombin receptors, Proteaseactivated Receptor, Protease Activated Receptor (PAR), Protease-Activated Receptor (PAR), ProteaseactivatedReceptor, AZ 3451, AZ3451, AZ-3451, inhibit, PAR-2, Inhibitor
Field of Research
Pharmacology & Drug Discovery
Purity
98.12% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.77 mM) ; H2O:Insoluble; DMSO:80 mg/mL (139.99 mM)
Smiles
C[C@@H] (C1CCCCC1) n1c (nc2cc (ccc12) C (=O) Nc1ccc (cc1) C#N) -c1cc2OCOc2cc1Br
Molecular Formula
C30H27BrN4O3
Molecular Weight
571.46
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.

Chemical Information

AZ3451

AZ3451 is a member of the class of benzimidazoles that is 1H-benzimidazole substituted by (1S)-1-cyclohexylethyl, 6-bromo-1,3-benzodioxol-5-yl, and 4-(cyanoanilino)acyl groups at positions 1, 2 and 5, respectively. It is an allosteric modulator of protease-activated receptor 2 (IC50 = 23 nM) and exhibits anti-osteoarthritis properties. It has a role as an autophagy inducer, a PAR2 negative allosteric modulator and an anti-inflammatory agent. It is a secondary carboxamide, a nitrile, a member of benzimidazoles, an organobromine compound and a member of benzodioxoles.

CAS Number2100284-59-9
PubChem CID126961335
IUPAC Name2-(6-bromo-1,3-benzodioxol-5-yl)-N-(4-cyanophenyl)-1-[(1S)-1-cyclohexylethyl]benzimidazole-5-carboxamide
Molecular FormulaC30H27BrN4O3
Molecular Weight571.5
XLogP6.9
Topological Polar Surface Area89.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Heavy Atom Count38
Formal Charge0
Complexity882
SMILES
C[C@@H](C1CCCCC1)N2C3=C(C=C(C=C3)C(=O)NC4=CC=C(C=C4)C#N)N=C2C5=CC6=C(C=C5Br)OCO6
InChI
InChI=1S/C30H27BrN4O3/c1-18(20-5-3-2-4-6-20)35-26-12-9-21(30(36)33-22-10-7-19(16-32)8-11-22)13-25(26)34-29(35)23-14-27-28(15-24(23)31)38-17-37-27/h7-15,18,20H,2-6,17H2,1H3,(H,33,36)/t18-/m0/s1
InChIKey
FJAOGFGHTPYADT-SFHVURJKSA-N
Chemical Structure
2D Structure
2D structure of AZ3451
CAS: 2100284-59-9
CID: 126961335
Formula: C30H27BrN4O3
MW: 571.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight571.5
XLogP36.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass570.12665
Monoisotopic Mass570.12665
Topological Polar Surface Area89.2 Ų
Heavy Atom Count38
Formal Charge0
Complexity882
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19208287-01AZ3971
GTR19203501-01AZ31

Alternative Products

CatalogName
BA5745-25AZ3451
A20204-2AZ3451 2mg
A20204-25AZ3451 25mg
A20204-10AZ3451 10mg
A20204-50AZ3451 50mg
A20204-100AZ3451 100mg
A20204-5AZ3451 5mg
A20204-10mM-DAZ3451 10mM * 1mL in DMSO

Popular Products